These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29880546)

  • 1. Effects of Repetitive Transendocardial CD34
    Vrtovec B; Poglajen G; Sever M; Zemljic G; Frljak S; Cerar A; Cukjati M; Jaklic M; Cernelc P; Haddad F; Wu JC
    Circ Res; 2018 Jul; 123(3):389-396. PubMed ID: 29880546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Transendocardial CD34
    Bervar M; Kozelj M; Poglajen G; Sever M; Zemljic G; Frljak S; Cukjati M; Cernelc P; Haddad F; Vrtovec B
    Stem Cells Transl Med; 2017 Jun; 6(6):1515-1521. PubMed ID: 28296283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of transendocardial CD34+ cell transplantation in patients with ischemic cardiomyopathy.
    Poglajen G; Sever M; Cukjati M; Cernelc P; Knezevic I; Zemljic G; Haddad F; Wu JC; Vrtovec B
    Circ Cardiovasc Interv; 2014 Aug; 7(4):552-9. PubMed ID: 25097199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
    Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
    Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy.
    Vrtovec B; Poglajen G; Lezaic L; Sever M; Socan A; Domanovic D; Cernelc P; Torre-Amione G; Haddad F; Wu JC
    Circulation; 2013 Sep; 128(11 Suppl 1):S42-9. PubMed ID: 24030420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34
    Frljak S; Jaklic M; Zemljic G; Cerar A; Poglajen G; Vrtovec B
    Stem Cells Transl Med; 2018 Feb; 7(2):168-172. PubMed ID: 29380563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic Network and Response to Intramyocardial CD34+ Stem Cell Therapy in Patients With Dilated Cardiomyopathy.
    Haddad F; Sever M; Poglajen G; Lezaic L; Yang P; Maecker H; Davis M; Kuznetsova T; Wu JC; Vrtovec B
    J Card Fail; 2015 Jul; 21(7):572-82. PubMed ID: 25863169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance.
    Vrtovec B; Sever M; Jensterle M; Poglajen G; Janez A; Kravos N; Zemljic G; Cukjati M; Cernelc P; Haddad F; Wu JC; Jorde UP
    Stem Cells Transl Med; 2016 May; 5(5):632-8. PubMed ID: 27025690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary transplantation of CD34(+) cells is associated with improved myocardial perfusion in patients with nonischemic dilated cardiomyopathy.
    Lezaic L; Socan A; Poglajen G; Peitl PK; Sever M; Cukjati M; Cernelc P; Wu JC; Haddad F; Vrtovec B
    J Card Fail; 2015 Feb; 21(2):145-52. PubMed ID: 25459687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transendocardial CD34
    Žorž N; Poglajen G; Frljak S; Knezevič I; Vrtovec B
    Cell Transplant; 2022; 31():9636897221080384. PubMed ID: 35320035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroanatomic Properties of the Myocardium Predict Response to CD34+ Cell Therapy in Patients With Ischemic and Nonischemic Heart Failure.
    Zemljic G; Poglajen G; Sever M; Cukjati M; Frljak S; Androcec V; Cernelc P; Haddad F; Vrtovec B
    J Card Fail; 2017 Feb; 23(2):153-160. PubMed ID: 27523610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Larger End-Diastolic Volume Associates With Response to Cell Therapy in Patients With Nonischemic Dilated Cardiomyopathy.
    Frljak S; Poglajen G; Zemljic G; Cerar A; Haddad F; Terzic A; Vrtovec B
    Mayo Clin Proc; 2020 Oct; 95(10):2125-2133. PubMed ID: 33012343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes of Autologous Stem Cell-Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy.
    Domae K; Miyagawa S; Yoshikawa Y; Fukushima S; Hata H; Saito S; Kainuma S; Kashiyama N; Iseoka H; Ito E; Harada A; Takeda M; Sakata Y; Toda K; Pak K; Yamada T; Sawa Y
    J Am Heart Assoc; 2021 Jul; 10(13):e008649. PubMed ID: 34212772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial.
    Hamshere S; Arnous S; Choudhury T; Choudry F; Mozid A; Yeo C; Barrett C; Saunders N; Gulati A; Knight C; Locca D; Davies C; Cowie MR; Prasad S; Parmar M; Agrawal S; Jones D; Martin J; McKenna W; Mathur A
    Eur Heart J; 2015 Nov; 36(44):3061-9. PubMed ID: 26333366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic
    Garcia-Pavia P; Palomares JFR; Sinagra G; Barriales-Villa R; Lakdawala NK; Gottlieb RL; Goldberg RI; Elliott P; Lee P; Li H; Angeli FS; Judge DP; MacRae CA;
    Circ Heart Fail; 2024 Jul; 17(7):e011548. PubMed ID: 38979608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
    Tompkins BA; Rieger AC; Florea V; Banerjee MN; Natsumeda M; Nigh ED; Landin AM; Rodriguez GM; Hatzistergos KE; Schulman IH; Hare JM
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of ARRY-371797 in
    MacRae CA; Taylor MRG; Mestroni L; Moses J; Ashley EA; Wheeler MT; Lakdawala NK; Hershberger RE; Sandor V; Saunders ME; Oliver C; Lee PA; Judge DP
    Circ Genom Precis Med; 2023 Feb; 16(1):e003730. PubMed ID: 36515663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of bone marrow mononuclear stem cell transplantation in patients with non-ischemic dilated cardiomyopathy-a meta analysis.
    Nso N; Bookani KR; Enoru ST; Radparvar F; Gordon R
    Heart Fail Rev; 2022 May; 27(3):811-820. PubMed ID: 33587248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.
    Fischer-Rasokat U; Assmus B; Seeger FH; Honold J; Leistner D; Fichtlscherer S; Schächinger V; Tonn T; Martin H; Dimmeler S; Zeiher AM
    Circ Heart Fail; 2009 Sep; 2(5):417-23. PubMed ID: 19808371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable Response to CD34+ Cell Therapy Is Associated with a Decrease of Galectin-3 Levels in Patients with Chronic Heart Failure.
    Poglajen G; Ksela J; Frljak S; Zemljic G; Boznar Alic E; Cerar A; Vrtovec B
    Dis Markers; 2019; 2019():8636930. PubMed ID: 31885743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.